KNSA vs SQ
Kiniksa Pharmaceuticals Ltd (KNSA) versus SQ (SQ) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
SQ (SQ) common stock.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
SQ does not have a complete income-statement cache yet.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the KNSA and SQ stock pages for the full models.
Not investment advice.